No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biomarkers, Tumor / analysis*
-
Breast Neoplasms / chemistry
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / prevention & control
-
Breast Neoplasms / radiotherapy
-
Breast Neoplasms / surgery
-
Breast Neoplasms / therapy*
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Female
-
Gene Expression Profiling*
-
Genetic Testing
-
Humans
-
Lymph Node Excision / methods
-
Mastectomy / methods*
-
Molecular Targeted Therapy* / methods
-
Mutation
-
Neoadjuvant Therapy / methods*
-
Primary Prevention / methods
-
Randomized Controlled Trials as Topic
-
Receptor, ErbB-2 / analysis
-
Receptors, Estrogen / analysis
-
Receptors, Progesterone / analysis
-
Risk Reduction Behavior*
-
Sentinel Lymph Node Biopsy
-
Triple Negative Breast Neoplasms / therapy
Substances
-
Antineoplastic Agents
-
Antineoplastic Agents, Hormonal
-
Biomarkers, Tumor
-
Receptors, Estrogen
-
Receptors, Progesterone
-
ERBB2 protein, human
-
Receptor, ErbB-2